1. RK Mellon Institute, Children’s Hospital of Pittsburgh of UPMC/University of Pittsburgh, Pittsburgh, PA;
2. Division of Rheumatology, Department of Internal Medicine Specialties, University Hospital of Geneva, Geneva, Switzerland;
3. Department of Pediatric Rheumatology and Immunology, University Children’s Hospital Muenster, Muenster, Germany;
4. Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany;
5. Translational Autoinflammatory Diseases Studies, National Institute of Allergy and Infectious Diseases, and
6. Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD;
7. Department of Pathology, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA;
8. AB2Bio, Ltd., Lausanne, Switzerland;
9. Pediatric Rheumatology, Cincinnati Children’s Hospital, Cincinnati, OH;
10. Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany; and
11. Division of Respirology, Neurology, and Rheumatology, Kurume University School of Medicine, Kurume, Japan